Cash flow MannKind Corporation

Equities

MNKD

US56400P7069

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 13/02/2026 GMT			5-day change	1st Jan Change
5.660 ^USD	+0.53%		-4.23%	-0.18%

02-09	MannKind Enrolls First Patient in Study Evaluating Afrezza Inhaled Insulin in Youth	MT
02-09	MannKind announces first patient enrolled in Inhale-1st pediatric study evaluating Afrezza® for youth with newly-diagnosed type 1 diabetes (T1d)	RE

2e79de490f5fb23aa9c.MtwzuxcTZGQB7W791LT0FBiUeUSDIBwAjEOv6rEUdqc.Wb5ZjX1MVwcylD-rv8CxVlXLKx7TDXR69Snwk_xBQ99GmUmWREUlCFGENw

Published financial data: MANNKIND CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	65.14M	75.44M	99.77M	199M	286M
Other Revenues, Total	-	-	-	-	-
Total Revenues	65.14M	75.44M	99.77M	199M	286M
Cost of Goods Sold, Total	24.64M	38.86M	57.5M	62.77M	76.6M
Gross Profit	40.5M	36.58M	42.27M	136M	209M
Selling General & Admin Expenses, Total	59.04M	77.42M	91.47M	94.31M	94.33M
Provision for Bad Debts	-	100K	-	-	-
R&D Expenses	6.25M	12.31M	19.72M	31.28M	45.89M
Other Operating Expenses, Total	65.29M	89.83M	111M	126M	140M
Operating Income	-24.78M	-53.24M	-68.92M	10.59M	68.68M
Interest Expense, Total	-9.47M	-16.58M	-24.77M	-25.16M	-37.98M
Interest And Investment Income	167K	112K	2.51M	6.15M	12.62M
Net Interest Expenses	-9.3M	-16.46M	-22.26M	-19.01M	-25.37M
Currency Exchange Gains (Loss)	-8.01M	6.57M	4.81M	-1.92M	3.91M
Other Non Operating Income (Expenses)	-1.87M	-578K	-102K	122K	32K
EBT, Excl. Unusual Items	-43.96M	-63.72M	-86.47M	-10.21M	47.25M
Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-932K	-170K	-1.55M
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-	-6K	-	-	-
In Process R&D Expenses	-13.23M	-	-	-	-
Other Unusual Items	-264K	-17.2M	-	-	-15.18M
EBT, Incl. Unusual Items	-57.46M	-80.93M	-87.4M	-10.38M	30.52M
Income Tax Expense	-218K	-	-	1.56M	2.93M
Earnings From Continuing Operations	-57.24M	-80.93M	-87.4M	-11.94M	27.59M
Net Income to Company	-57.24M	-80.93M	-87.4M	-11.94M	27.59M
Net Income - (IS)	-57.24M	-80.93M	-87.4M	-11.94M	27.59M
Net Income to Common Incl Extra Items	-57.24M	-80.93M	-87.4M	-11.94M	27.59M
Net Income to Common Excl. Extra Items	-57.24M	-80.93M	-87.4M	-11.94M	27.59M
Per Share Items
Net EPS - Basic	-0.26	-0.32	-0.34	-0.04	0.1
Basic EPS - Continuing Operations	-0.26	-0.32	-0.34	-0.04	0.1
Basic Weighted Average Shares Outstanding	223M	249M	257M	267M	274M
Net EPS - Diluted	-0.26	-0.32	-0.34	-0.04	0.1
Diluted EPS - Continuing Operations	-0.26	-0.32	-0.34	-0.04	0.1
Diluted Weighted Average Shares Outstanding	223M	249M	257M	267M	284M
Normalized Basic EPS	-0.12	-0.16	-0.21	-0.02	0.11
Normalized Diluted EPS	-0.12	-0.16	-0.21	-0.02	0.1
Supplemental Items
EBITDA	-22.9M	-49.41M	-63.23M	15.13M	76.05M
EBITA	-24.78M	-53.24M	-68.92M	10.59M	68.68M
EBIT	-24.78M	-53.24M	-68.92M	10.59M	68.68M
EBITDAR	-21.1M	-48.03M	-61.43M	16.91M	78.39M
Total Revenues (As Reported)	65.14M	75.44M	99.77M	199M	286M
Effective Tax Rate - (Ratio)	0.38	-	-	-15.04	9.6
Current Domestic Taxes	-	-	-	1.56M	2.75M
Current Foreign Taxes	-218K	-	-	-	165K
Total Current Taxes	-218K	-	-	1.56M	2.92M
Deferred Domestic Taxes	0	0	0	6K	15K
Total Deferred Taxes	0	0	0	6K	15K
Normalized Net Income	-27.48M	-39.82M	-54.04M	-6.38M	29.53M
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	5.16M	16.58M	24.77M	24.98M	21.81M
Supplemental Operating Expense Items
Selling and Marketing Expenses	-	-	53.75M	51.78M	-
General and Administrative Expenses	-	-	35.92M	40.76M	-
Research And Development Expense From Footnotes	19.48M	12.31M	19.72M	31.28M	45.89M
Net Rental Expense, Total	1.8M	1.38M	1.8M	1.78M	2.34M
Imputed Operating Lease Interest Expense	1.11M	722K	928K	939K	2.67M
Imputed Operating Lease Depreciation	686K	656K	871K	840K	-331K
Stock-Based Comp., COGS (Total)	1.07M	2.12M	1.75M	2.49M	4.06M
Stock-Based Comp., R&D Exp. (Total)	338K	614K	1.04M	1.44M	2.24M
Stock-Based Comp., S&M Exp. (Total)	-	-	1.19M	2.29M	-
Stock-Based Comp., G&A Exp. (Total)	-	-	9.46M	11.43M	-
Stock-Based Comp., SG&A Exp. (Total)	5.1M	9.47M	-	-	15.06M
Total Stock-Based Compensation	6.51M	12.2M	13.45M	17.65M	21.36M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	67M	124M	69.77M	238M	46.34M
Short Term Investments	-	79.93M	101M	63.52M	157M
Total Cash And Short Term Investments	67M	204M	171M	302M	204M
Accounts Receivable, Total	4.22M	4.74M	16.8M	14.9M	35.86M
Other Receivables	-	255K	-	-	1M
Total Receivables	4.22M	4.99M	16.8M	14.9M	36.86M
Inventory	4.97M	7.15M	21.77M	28.54M	27.89M
Prepaid Expenses	3.12M	3.48M	25.48M	27.95M	-
Restricted Cash	158K	-	-	-	-
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	79.48M	220M	235M	373M	268M
Gross Property Plant And Equipment	123M	134M	144M	190M	205M
Accumulated Depreciation	-96.82M	-97.66M	-98.56M	-102M	-107M
Net Property Plant And Equipment	25.87M	36.61M	45.13M	88.9M	98.47M
Long-term Investments	-	59.62M	9.06M	7.16M	5.48M
Goodwill	-	-	2.43M	1.93M	1.93M
Other Intangibles, Total	-	-	1.15M	1.07M	5.26M
Other Long-Term Assets, Total	3.26M	5.19M	2.62M	2.74M	14.38M
Total Assets	109M	321M	295M	475M	394M
Liabilities
Accounts Payable, Total	5.58M	7.83M	11.05M	9.58M	6.79M
Accrued Expenses, Total	16.09M	21.31M	26.75M	32.18M	31.58M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	4.06M	-	-	20M	-
Current Portion of Leases	-	6.98M	10.87M	11.23M	12.48M
Current Income Taxes Payable	-	-	-	1.56M	49K
Unearned Revenue Current, Total	33.28M	827K	1.73M	9.08M	12.41M
Other Current Liabilities	14.7M	11.4M	16.9M	20.49M	18.53M
Total Current Liabilities	73.7M	48.35M	67.3M	104M	81.84M
Long-Term Debt	118M	281M	273M	249M	36.05M
Long-Term Leases	1.2M	94.56M	99.86M	98.24M	106M
Unearned Revenue Non Current	1.66M	24.49M	37.68M	69.79M	51.16M
Other Non Current Liabilities	94.28M	81.9M	67.5M	201M	198M
Total Liabilities	289M	531M	546M	721M	473M
Common Stock, Total	2.42M	2.52M	2.64M	2.7M	3.03M
Additional Paid In Capital	2.87B	2.92B	2.96B	2.98B	3.12B
Retained Earnings	-3.05B	-3.13B	-3.22B	-3.23B	-3.2B
Comprehensive Income and Other	-	-	-	-	1.11M
Total Common Equity	-180M	-209M	-251M	-246M	-78.82M
Total Equity	-180M	-209M	-251M	-246M	-78.82M
Total Liabilities And Equity	109M	321M	295M	475M	394M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	247M	252M	264M	270M	304M
ECS Total Common Shares Outstanding	242M	251M	264M	270M	303M
Book Value / Share	-0.75	-0.83	-0.95	-0.91	-0.26
Tangible Book Value	-180M	-209M	-254M	-249M	-86.01M
Tangible Book Value Per Share	-0.75	-0.83	-0.96	-0.92	-0.28
Total Debt	123M	383M	384M	378M	154M
Net Debt	56.43M	179M	213M	76.18M	-49.5M
Debt Equivalent Oper. Leases	14.4M	11.02M	14.39M	14.23M	18.7M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	1.39M	2.7M	5.74M	6.26M	6.18M
Inventories - Work In Process, Total	2.48M	2.52M	13.82M	13.65M	10.66M
Inventories - Finished Goods, Total	1.1M	1.93M	2.22M	8.64M	11.04M
Land - (BS)	875K	875K	875K	875K	875K
Buildings, Total	54.93M	56.04M	56.34M	63.75M	108M
Machinery, Total	66.38M	66.47M	69.76M	72.14M	76.82M
Full Time Employees	240	348	391	411	403
Part Time Employees	1	1	4	3	4
Accumulated Allowance for Doubtful Accounts (Supple)	-	767K	-	157K	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-57.24M	-80.93M	-87.4M	-11.94M	27.59M
Depreciation & Amortization - CF	3.06M	5.1M	8.68M	5.84M	9.04M
Depreciation & Amortization, Total	3.06M	5.1M	8.68M	5.84M	9.04M
Amortization of Deferred Charges, Total - (CF)	268K	377K	431K	2.08M	1.65M
(Gain) Loss From Sale Of Asset	-	-	-	-	565K
(Gain) Loss on Sale of Investments - (CF)	-	-	932K	-755K	-3.54M
Asset Writedown & Restructuring Costs	15.12M	106K	-	-	-
Stock-Based Compensation (CF)	6.51M	12.2M	13.45M	17.65M	21.36M
Other Operating Activities, Total	13.93M	19.17M	7.28M	6.59M	22.33M
Change In Accounts Receivable	-705K	-776K	-11.81M	2.34M	2.65M
Change In Inventories	-1.31M	-4.08M	-5.67M	-11.35M	-3.2M
Change In Accounts Payable	793K	1.37M	4.1M	-1.47M	-2.79M
Change in Unearned Revenues	-5.91M	-9.62M	14.1M	39.46M	-15.31M
Change in Other Net Operating Assets	-2.64M	-4.63M	-24.77M	-14.36M	-17.83M
Cash from Operations	-28.13M	-61.71M	-80.68M	34.09M	42.51M
Capital Expenditure	-801K	-11.47M	-7.59M	-42.44M	-9.69M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-	-15.34M	-	-
Sale (Purchase) of Intangible assets	-3.98M	-	-	-	-
Investment in Marketable and Equity Securities, Total	20M	-140M	27.8M	40.07M	-87.35M
Other Investing Activities, Total	-	-	-	382K	396K
Cash from Investing	15.22M	-152M	4.87M	-1.99M	-96.65M
Long-Term Debt Issued, Total	14.87M	332M	-	-	-
Total Debt Issued	14.87M	332M	-	-	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-	-47.05M	-18K	-6.86M	-134M
Total Debt Repaid	-	-47.05M	-18K	-6.86M	-134M
Issuance of Common Stock	35.5M	1.99M	22.88M	8.71M	3.14M
Repurchase of Common Stock	-	-498K	-	-10.16M	-6.09M
Other Financing Activities, Total	-518K	-16.43M	-1.47M	145M	-752K
Cash from Financing	49.85M	270M	21.39M	137M	-137M
Net Change in Cash	36.94M	57.02M	-54.42M	169M	-191M
Supplemental Items
Cash Interest Paid	3.56M	11.27M	8.85M	18.28M	17.51M
Cash Income Tax Paid (Refund)	-	-	-	-	4.26M
Levered Free Cash Flow	-8.9M	-68.86M	-75.83M	-23.95M	44.64M
Unlevered Free Cash Flow	-3.25M	-58.88M	-60.78M	-10.31M	66.73M
Change In Net Working Capital	-7.46M	31.43M	32.24M	-2.02M	-3.1M
Net Debt Issued / Repaid	14.87M	285M	-18K	-6.86M	-134M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-15.31	-15.49	-13.98	1.72	9.88
Return on Total Capital	24.57	-57.17	-27.93	4.98	41.42
Return On Equity %	30.86	41.53	38.01	4.81	-16.98
Return on Common Equity	30.86	41.53	38.01	4.81	-16.98
Margin Analysis
Gross Profit Margin %	62.17	48.49	42.37	68.45	73.17
SG&A Margin	90.63	102.62	91.68	47.4	33.04
EBITDA Margin %	-35.16	-65.49	-63.37	7.6	26.64
EBITA Margin %	-38.05	-70.58	-69.08	5.32	24.06
EBIT Margin %	-38.05	-70.58	-69.08	5.32	24.06
Income From Continuing Operations Margin %	-87.87	-107.27	-87.6	-6	9.66
Net Income Margin %	-87.87	-107.27	-87.6	-6	9.66
Net Avail. For Common Margin %	-87.87	-107.27	-87.6	-6	9.66
Normalized Net Income Margin	-42.18	-52.79	-54.17	-3.21	10.34
Levered Free Cash Flow Margin	-13.66	-91.28	-76	-12.04	15.64
Unlevered Free Cash Flow Margin	-4.99	-78.04	-60.92	-5.18	23.37
Asset Turnover
Asset Turnover	0.64	0.35	0.32	0.52	0.66
Fixed Assets Turnover	2.47	2.41	2.44	2.83	3.05
Receivables Turnover (Average Receivables)	16.85	16.85	9.26	12.55	7.88
Inventory Turnover (Average Inventory)	5.4	6.41	3.98	2.5	2.71
Short Term Liquidity
Current Ratio	1.08	4.54	3.49	3.59	3.28
Quick Ratio	0.97	4.33	2.79	3.04	2.94
Operating Cash Flow to Current Liabilities	-0.38	-1.28	-1.2	0.33	0.52
Days Sales Outstanding (Average Receivables)	21.72	21.67	39.4	29.08	46.45
Days Outstanding Inventory (Average Inventory)	67.79	56.95	91.81	146.29	134.81
Average Days Payable Outstanding	74.55	59.65	47.79	54.14	39.45
Cash Conversion Cycle (Average Days)	14.96	18.96	83.42	121.23	141.81
Long Term Solvency
Total Debt/Equity	-68.42	-182.83	-153.36	-153.62	-195.47
Total Debt / Total Capital	-216.62	220.74	287.42	286.48	204.75
LT Debt/Equity	-66.17	-179.49	-149.02	-140.94	-179.62
Long-Term Debt / Total Capital	-209.5	216.71	279.29	262.82	188.16
Total Liabilities / Total Assets	266.12	165.18	184.85	151.8	120.01
EBIT / Interest Expense	-2.62	-3.21	-2.78	0.42	1.81
EBITDA / Interest Expense	-2.23	-2.9	-2.48	0.67	2.06
(EBITDA - Capex) / Interest Expense	-2.31	-3.59	-2.79	-1.01	1.81
Total Debt / EBITDA	-5.85	-7.97	-6.25	22.37	1.97
Net Debt / EBITDA	-2.67	-3.72	-3.47	4.51	-0.63
Total Debt / (EBITDA - Capex)	-5.64	-6.43	-5.57	-14.81	2.24
Net Debt / (EBITDA - Capex)	-2.58	-3	-3.09	-2.98	-0.72
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	3.34	15.81	32.25	99.42	43.5
Gross Profit, 1 Yr. Growth %	15.53	-9.67	15.55	222.17	53.39
EBITDA, 1 Yr. Growth %	-50.03	115.71	27.98	-123.06	402.68
EBITA, 1 Yr. Growth %	-46.71	114.82	29.44	-115.37	548.29
EBIT, 1 Yr. Growth %	-46.71	114.82	29.44	-115.37	548.29
Earnings From Cont. Operations, 1 Yr. Growth %	10.28	41.38	8	-86.34	-331.09
Net Income, 1 Yr. Growth %	10.28	41.38	8	-86.34	-331.09
Normalized Net Income, 1 Yr. Growth %	-20.69	44.95	35.7	-88.2	-562.95
Diluted EPS Before Extra, 1 Yr. Growth %	-3.1	26.26	4.7	-86.85	-323.67
Accounts Receivable, 1 Yr. Growth %	20.07	12.35	254.53	-11.31	-2.01
Inventory, 1 Yr. Growth %	19.69	43.82	204.42	31.11	-2.31
Net Property, Plant and Equip., 1 Yr. Growth %	-3.4	41.54	23.25	71.5	10.76
Total Assets, 1 Yr. Growth %	15.88	195.71	-8.06	60.93	-17.12
Tangible Book Value, 1 Yr. Growth %	-5.3	16.03	21.39	-1.95	-65.48
Common Equity, 1 Yr. Growth %	-5.3	16.03	19.67	-1.74	-67.98
Cash From Operations, 1 Yr. Growth %	-68.21	119.39	30.74	-142.26	24.69
Capital Expenditures, 1 Yr. Growth %	-68.77	1.33K	-33.81	459.24	-77.16
Levered Free Cash Flow, 1 Yr. Growth %	-73.53	673.62	8.35	-65.5	-286.36
Unlevered Free Cash Flow, 1 Yr. Growth %	-88.01	1.71K	1.3	-81.6	-747.08
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	52.92	9.4	23.76	62.4	69.16
Gross Profit, 2 Yr. CAGR %	134.11	2.15	2.16	92.94	122.3
EBITDA, 2 Yr. CAGR %	-46.28	3.82	66.15	-45.62	7.67
EBITA, 2 Yr. CAGR %	-44.71	6.99	66.76	-55.35	-0.18
EBIT, 2 Yr. CAGR %	-44.71	6.99	66.76	-55.35	-0.18
Earnings From Cont. Operations, 2 Yr. CAGR %	-18.88	24.87	23.57	-61.59	-43.82
Net Income, 2 Yr. CAGR %	-18.88	24.87	23.57	-61.59	-43.82
Normalized Net Income, 2 Yr. CAGR %	-28.49	7.22	40.25	-59.95	-26.08
Diluted EPS Before Extra, 2 Yr. CAGR %	-34.72	10.61	14.98	-62.89	-45.77
Accounts Receivable, 2 Yr. CAGR %	2.47	16.15	99.58	77.32	46.1
Inventory, 2 Yr. CAGR %	17.58	31.2	109.24	99.78	13.17
Net Property, Plant and Equip., 2 Yr. CAGR %	0.52	16.93	32.08	55.83	37.83
Total Assets, 2 Yr. CAGR %	0.42	85.11	64.89	21.64	15.49
Tangible Book Value, 2 Yr. CAGR %	1.51	4.82	18.68	9.1	-41.82
Common Equity, 2 Yr. CAGR %	1.51	4.82	17.84	8.44	-43.91
Cash From Operations, 2 Yr. CAGR %	-13.66	-16.49	69.36	-25.67	-27.41
Capital Expenditures, 2 Yr. CAGR %	50.42	111.43	207.81	92.39	13.02
Levered Free Cash Flow, 2 Yr. CAGR %	-24.32	43.11	191.88	-41.69	-19.82
Unlevered Free Cash Flow, 2 Yr. CAGR %	-45.13	47.39	332.48	-59.15	9.12
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	80.14	39.38	16.54	45.09	55.84
Gross Profit, 3 Yr. CAGR %	88.13	70.43	6.44	49.81	78.74
EBITDA, 3 Yr. CAGR %	-37.4	-14.61	11.32	-12.91	14.13
EBITA, 3 Yr. CAGR %	-36.14	-13.07	14.01	-24.67	8.92
EBIT, 3 Yr. CAGR %	-36.14	-13.07	14.01	-24.67	8.92
Earnings From Cont. Operations, 3 Yr. CAGR %	-21.28	-2.37	18.97	-40.7	-30.14
Net Income, 3 Yr. CAGR %	-21.28	-2.37	18.97	-40.7	-30.14
Normalized Net Income, 3 Yr. CAGR %	-27.65	-9.5	15.98	-38.54	-9.44
Diluted EPS Before Extra, 3 Yr. CAGR %	-38.95	-18.66	8.61	-44.19	-32.47
Accounts Receivable, 3 Yr. CAGR %	14.79	5.66	68.48	52.3	96.33
Inventory, 3 Yr. CAGR %	23.24	25.75	73.69	79.05	57.39
Net Property, Plant and Equip., 3 Yr. CAGR %	-1.32	12.66	19	50.91	39.07
Total Assets, 3 Yr. CAGR %	8.69	43.93	46.6	63.56	7.04
Tangible Book Value, 3 Yr. CAGR %	-5.64	6.14	10.08	11.36	-25.66
Common Equity, 3 Yr. CAGR %	-5.64	6.14	9.56	10.91	-27.79
Cash From Operations, 3 Yr. CAGR %	-24.28	17.82	-3.03	6.62	-11.68
Capital Expenditures, 3 Yr. CAGR %	-	218.76	43.56	275.59	-5.45
Levered Free Cash Flow, 3 Yr. CAGR %	31.28	64.25	31.14	39.09	-14.11
Unlevered Free Cash Flow, 3 Yr. CAGR %	7.28	76.02	30.9	46.95	2.6
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-15.47	55.02	48.17	35.27
Gross Profit, 5 Yr. CAGR %	-8.96	-21.75	47.36	79.1	42.9
EBITDA, 5 Yr. CAGR %	-28.63	-5.4	-7.5	-28.21	10.66
EBITA, 5 Yr. CAGR %	-28.79	-3.25	-6.25	-33.43	8.11
EBIT, 5 Yr. CAGR %	-28.79	-3.25	-6.25	-33.43	8.11
Earnings From Cont. Operations, 5 Yr. CAGR %	-31.09	-8.43	-5.72	-32.78	-11.87
Net Income, 5 Yr. CAGR %	-31.09	-8.43	-5.72	-32.78	-11.87
Normalized Net Income, 5 Yr. CAGR %	-27.99	3.02	-5.72	-34.7	-3.14
Diluted EPS Before Extra, 5 Yr. CAGR %	-43.68	-24.91	-21.36	-40.58	-17.73
Accounts Receivable, 5 Yr. CAGR %	-	73.43	43.21	29.98	59.15
Inventory, 5 Yr. CAGR %	-	25.13	52.3	51.33	46.34
Net Property, Plant and Equip., 5 Yr. CAGR %	-11.9	4.82	10.88	28.27	29.75
Total Assets, 5 Yr. CAGR %	-2.99	24.57	28.41	34.56	33.26
Tangible Book Value, 5 Yr. CAGR %	-12.43	2.66	3.43	7.31	-14.71
Common Equity, 5 Yr. CAGR %	-12.43	2.66	3.13	7.05	-16.18
Cash From Operations, 5 Yr. CAGR %	-13.24	-4.6	4.49	-2.01	-13.64
Capital Expenditures, 5 Yr. CAGR %	-39.98	58.56	-	160.47	30.46
Levered Free Cash Flow, 5 Yr. CAGR %	-32.28	-16.94	80.71	9.04	5.83
Unlevered Free Cash Flow, 5 Yr. CAGR %	-41.88	-18.56	87.37	-0.91	19.75